A POPULATION PHARMACOKINETIC MODELING APPROACH TO EVALUATE THE CURRENT DOSING RECOMMENDATIONS OF FAVIPIRAVIR IN EGYPTIAN SUBJECTS

INTRO: Favipiravir is approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for managing emerging influenza and is under investigation for treating SARS-CoV-2 cases. While favipiravir's pharmacokinetics is similar between healthy and infected subjects, a previous study repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Salem, A., Gouda, A., Marzouk, H., Rezk, M., Abdel-Megied, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186905/
http://dx.doi.org/10.1016/j.ijid.2023.04.234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186905/
http://dx.doi.org/10.1016/j.ijid.2023.04.234

Ejemplares similares